Please login to the form below
Janssen
This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.
Janssen’s Tremfya receives positive results for active psoriatic arthritis
established safety,” said Terence Rooney, vice president, Rheumatology and Maternal-Fetal Immunology Disease Area leader at Janssen Research &Development. ... Through using the NMA approach to trial data, companies like Janssen are able to provide
Latest news
-
Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
Other gold winning pharma companies and healthcare organisations included Biotest AG, Edwards Life Sciences, Frontline.Live, Huntleigh, Galderma, GlaxoSmithKline, Janssen Pharmaceutica NV, Norgine, Santen and Takeda UK. ... Peer to peer programme by Wave
-
J&J and Pfizer quietly resolve Remicade biosimilar lawsuit
Janssen [J&J’s pharma division] has always been and remains committed to ensuring that our medicines – including Remicade – are accessible for patients and doctors who choose them.
-
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
In an amendment to the fact sheet for the vaccine, the FDA has now included the following information: “Guillain Barré syndrome […] has occurred in some people who have received the Janssen ... In most of these people, symptoms began within 42 days
-
J&J’s COVID-19 vaccine shows ‘strong’ activity against Delta variant
In addition, we observe a persistent and particularly robust, durable cellular immune response,” said Mathai Mammen, global head, Janssen Research &Development, Johnson &Johnson.
-
CHMP recommends eight new medicines for EU approval
Two generic medicines also received positive opinions from the CHMP: Abiraterone Mylan (abiraterone acetate), a generic of Janssen’s Zytiga, for the treatment of metastatic prostate cancer and Fingolimod Mylan (fingolimod),
More from news
Approximately 142 fully matching, plus 411 partially matching documents found.
Latest Intelligence
-
Are healthcare brands finally wising up to the power of creative-led communications?
And the list goes on. So it seems, encouragingly, that health and pharma brands – from Pfizer to Teva and Roche Genentech to Janssen – seem to finally be recognising the power of
-
Understanding the ‘real world’ starts and ends with the patient
For the past 20 years, true understanding of the patient experience has been the turnkey for R&D for therapies in pulmonary arterial hypertension (PAH) at Janssen Pulmonary Hypertension (following the ... PAH treatment strategies or interventions, an
-
Unlocking the potential of precision medicine in oncology
Joaquín Casariego García-Lubén talks to PME about how Janssen is driven by the premise of providing personalised treatment solutions in cancer care. ... Joaquín Casariego García-Lubén is EMEA Therapeutic Area Lead Oncology, The Janssen
-
Switzerland: a life sciences hub
The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.
-
Will biosimilars ever catch on in the US?
Pfizer also cited a Janssen brochure that allegedly implied the biosimilar Inflectra is not interchangeable with Remicade and may pose a safety risk.
More from intelligence
Approximately 5 fully matching, plus 54 partially matching documents found.
Latest appointments
-
Genmab appoints Tahamtan Ahmadi as chief medical officer, head of experimental medicines
Prior to Genmab, Ahmadi worked as head of experimental medicine and early development oncology at Janssen.
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
During her time at J&J, Torres held several executive leadership roles including president of McNeil Consumer Healthcare and president of Janssen Pharmaceuticals, CNS.
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his career at Johnson &Johnson and Janssen.
-
Robert Freisen joins Ablynx
He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.
-
Mundipharma appoints Dr Alberto Martinez as president and CEO
Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.
More from appointments
Approximately 3 fully matching, plus 27 partially matching documents found.
Latest from PMHub
-
OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:. The Immunology Training Summit (ITS) 2020 with the Janssen EMEA Immunology team took a week-long face-to-face meeting for ... Strikingly this format is now considered best practice in
-
Mednet Group
Clinigen. Crohns and Colitis Department for International Development. Eisai. Gilead. Janssen.
-
If our patients are diverse, why are clinical trials so white?
Darzalex is made by Janssen Oncology, a company under Johnson &Johnson. ... Janssen are not alone in trying to make clinical trials more representative.
-
Havas Lynx Group
Grϋnenthal. Janssen. Lilly. Lundbeck. Merck Serono. Novartis. Novo Nordisk. Pfizer. Roche.
-
EPG Health
Strategic planning - to ensure ongoing engagement and success. Alexion, Almirall, Alnylam, AstraZeneca, Bial, Biogen, Bluebird Bio, Boehringer Ingelheim, BMS, CSL Behring, Ferring, Four Health, GSK, HRA Pharma, Janssen, Leo Pharma, Lilly,
Mednet Group
Havas Lynx Group
EPG Health
More from PMHub
Approximately 5 fully matching, plus 28 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
-
Account Manager
-
Competitive salary with bonus and benefits
-
Head of Copy
-
£ competitive
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Home or away: where next for pharmaceutical symposia?
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- FDA grants priority review for Roche’s Evrysdi for spinal muscular atrophy in babies
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- Pfizer’s Paxlovid receives positive opinion from CHMP
- Moderna begins phase 2 trial of Omicron-specific booster
- Expanding Access to High-Quality Healthcare
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Janssen’s Tremfya receives positive results for active psoriatic arthritis
- ARISE - a strategic healthcare communication planning process from Bedrock
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- Personalised medicine: driving a need for greater diversity in clinical trials
- Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
